Jakarta Setiabudi Internasional Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Jakarta Setiabudi Internasional Tbk trades at Rp1,415 (market cap 3.25T, 7.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Jakarta Setiabudi Internasional Tbk is far larger — about 5.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 7.5K). Which is the better fit depends on your goals.
| JSPT | LABS | |
|---|---|---|
Market Cap | 3.25T | 576.7B |
Volume | 7.5K | 3.48M |
Lot | 75 | 34.82K |
Turnover | 10.56M | 522.79M |
Average Price | 1,408 | 150.13 |
Value | 10.56M | 522.79M |
Indicative Equilibrium Price | — | 148 |
Indicative Equilibrium Volume | — | 350 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Jakarta Setiabudi Internasional Tbk (the Company) was established in the Republic of Indonesia within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 4 dated July 2, 1975 of Imas Fatimah, S.H., as amended by Notarial Deed No. 15 dated September 11, 1975 of the same notary. At the first time until 1996 this company was focusing in construction. Leasing and office building maintanance and apartment surrounding Kuningan area, Jakarta.
Read more on JSPT →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →